Dr. Laurent Nguyen, a French national, graduated as Doctor of Medicine and holds a Master’s Degree in Public Health. Following a 4-year residency at the Paris Hospital Group, he built a solid international 20-year experience in marketing & sales and business Development & Licensing in the pharmaceutical industry at Hoechst-Roussel, Merck KGaA, F. Hoffmann-La Roche Ltd and Pierre Fabre. He then moved to the biotech sector in 2012 where he started as CEO of Sensorion, a French private academic spin-off in neurotology that he developed into a publicly traded clinical biotech company on Euronext Growth (ALSEN). He then moved to Bionure, a Spanish academic spin-off that he merged as co-founder with iProteos to form in 2020 Accure Therapeutics, a translational R&D engine specialized in CNS. Based on his experience as seasoned C-level executive, he also acted as advisor in corporate development for several biotech and medtech companies.